Pen Dosage Chart Dosage & Protocols Variations Standard Research Protocol Dose: 1 mg Tesamorelin + 200 mcg Ipamorelin Duration: 8 12 weeks Frequency: Once daily, evening (pre-sleep) Cycle Interval: 4 weeks off before repeating Goal / Description: Baseline GHRH/GHRP co-stimulation in body composition models
A provider should review your health history, labs, symptoms, sleep, recovery, body composition goals, medications, and risk factors before recommending any peptide plan
Effective interventions exist, and addressing incontinence early prevents the compensatory behaviors, like limiting fluid intake, that can actually increase UTI risk
Pan-HDAC inhibitors lack isoform specificity and may induce cytotoxicity or even cardiotoxicity (e.g., QT prolongation) at high doses, and currently, no HDACi is approved specifically for cardiovascular indications 156,168